Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single and Multiple Ascending Doses of DS-5565 (mirogabalin) in Healthy Chinese Subjects
jRCT1080223624Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial comparing mirogabalin with Placebo (2 arms). Primary endpoints: Safety and tolerability of DS-5565 (mirogabalin) and Pharmacokinetics of DS-5565 (mirogabalin). Started Aug 2017; status: completed.
02
Drugs
mirogabalin
Beyond the preview
Go deeper on jRCT1080223624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223624.